Key result
Ultrasound-enhancing agents increase echocardiographic diagnostic accuracy by ~97% for structural abnormalities, matching CMR.
Why the study?
Ultrasound-enhanced echocardiography improves diagnostic accuracy for assessing ventricular function and identifying structural abnormalities.
Case Report
The use of ultrasound-enhancing agents significantly improves the diagnostic accuracy of echocardiography, making it comparable to cardiovascular magnetic resonance for assessing ventricular function and structural abnormalities.
Answers are grounded in this paper and cite their sources.
Ultrasound-enhancing agents may boost echocardiographic accuracy for structural assessment; leaves open routine equivalence to CMR pending higher-level trials.
Ultrasound-enhanced echocardiography is used in clinical cardiology to assess the regional and global left ventricular and right ventricular systolic function at rest and during stress. It can also assist in the identification of structural abnormalities such as apical hypertrophic cardiomyopathy, noncompaction, left ventricular pseudoaneurysm, cardiac thrombi, and tumors.1-3 The diagnostic accuracy of echocardiography when using ultrasound-enhancing agents (UEAs) for the above indications increases by 97% and is comparable to cardiovascular magnetic resonance.
No takes yet. Share an insight, caveat, or question.
Meraihi et al. (2026) conducted a case report in Postoperative cardiac complications. Ultrasound-enhancing agents (UEAs) was evaluated. The use of ultrasound-enhancing agents during echocardiography increases diagnostic accuracy by 97%, rendering it comparable to cardiovascular magnetic resonance for structural abnormalities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: